DNA Chip Research Inc. (2397.T)

1,075.00 +2.00 (+0.19%) At close: 03:15PM JST

DNA Chip Research Inc.

Suzue Baydium
5th Floor 1-15-1 Kaigan Minato-ku
Tokyo 105-0022
Japan
81 3 5777 1700
https://www.dna-chip.co.jp

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 36

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Ryo Matoba Ph.D.	President, CEO & Representative Director	N/A	N/A	1965
Mr. Kenichi Matsubara Ph.D.	Founder	N/A	N/A	1934
Keiji Sato	GM of Diagnostic Business Headquarters & Director	N/A	N/A	1978

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.

Description

DNA Chip Research Inc. develops DNA microarrays in Japan. The company offers research and development, contract research, and diagnostic support services. It offers Tbone EX Kit for Japanese forensic laboratories in police force and universities. The company also develops EGFR (epidermal growth factor receptor) Liquid gene analysis software, a disease diagnosis program for detecting mutations in the gene encoding EGFR using DNA extracted from plasma samples or cancer tissues and determining drug efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer, as well as focuses on developing a gene panel for testing cancers using sequencing technology. The company was incorporated in 1999 and is based in Tokyo, Japan.

Corporate governance

DNA Chip Research Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.